Detecting fibrosis without a liver biopsy: Getting to the fat of the issue

Research output: Contribution to journalReview article

Abstract

It is critical to assess the degree of liver fibrosis for clinical management. However, liver biopsy has many drawbacks and is invasive. Promising non-invasive methods including serum markers and new imaging studies to predict liver fibrosis have been developed in past decades. This editorial provides a succinct overview and update of the new non-invasive technologies, especially the three-dimensional magnetic resonance imaging (3-D MRI) that has been studied by Dr. Kawamura's group in Japan. It also highlights the merit and weakness of this 3D-MRI technology in predicting liver fibrosis and indicates future studies to understand where 3D-MRI fits into the current armamentarium of non-invasive serum-based and imaging technologies.

Original languageEnglish (US)
Pages (from-to)792-794
Number of pages3
JournalHepatology International
Volume7
Issue number3
DOIs
StatePublished - Jul 1 2013

    Fingerprint

Keywords

  • Liver fibrosis
  • MRI
  • NAFLD
  • Noninvasive
  • Serum marker

ASJC Scopus subject areas

  • Hepatology

Cite this